AARTIPHARM.BOAARTIPHARM.BOBSE
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+66.1%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+66.1%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
4.6x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$328.32M+292.3%
2024$83.70M-40.0%
2023$139.60M+94.9%
2022$71.64M-
2021$0.00-
2020$0.00-